Provided by Tiger Trade Technology Pte. Ltd.

Merck

147.76
-0.5900-0.40%
Pre-market: 148.831.07+0.72%04:02 EDT
Volume:11.13M
Turnover:1.64B
Market Cap:364.55B
PE:116.09
High:148.69
Open:147.00
Low:145.95
Close:148.35
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.03
T/O Rate:0.45%
Dividend:3.32
Dividend Rate:2.25%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.69
PE(LYR):20.30

Loading ...

Health Canada Approves Keytruda® for the Treatment of Adult Patients with Muscle Invasive Bladder Cancer Who are Ineligible for Cisplatin Containing Chemotherapy, in Combination with Enfortumab Vedotin, as Neoadjuvant Treatment and Then Continued After Radical Cystectomy as Adjuvant Treatment

THOMSON REUTERS
·
Aug 05

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Merck & Company (MRK) Receives a Buy from Barclays

TIPRANKS
·
Aug 05

U.S. Research Roundup-Ametek, Ball Corp, McDonald's

Reuters
·
Aug 05

Why Merck Just Slashed Its Profit Outlook By Nearly 50%

Benzinga Earnings
·
Aug 05

Merck's Weekly HIV Treatment Pipeline 'Interesting,' UBS Says

MT Newswires Live
·
Aug 05

U.S. Stocks on the MOVE-Expeditors International, Waters, Wayfair

Reuters
·
Aug 05

Top Midday Stories: Bessent Says US, Iran Could Soon Reach Hormuz Deal; Palantir Shares Soar on Strong Q2 Results, Guidance

MT Newswires Live
·
Aug 05

Merck & Co Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Sector Update: Healthcare

MT Newswires Live
·
Aug 04

Dow Jones Top Company Headlines at 9 am ET: McDonald's Aims to Improve Service and Food, and Chose a New U.S. Boss to Help | Pfizer's ...

Dow Jones
·
Aug 04

Merck Raises Revenue Forecast on Strong New Drug Sales, Cuts Profit Guidance Due to Acquisition Costs

Deep News
·
Aug 04

Acquisition Expenses Drag Down Earnings, Merck Reduces Annual Profit Forecast

Deep News
·
Aug 04

Coherent, Palantir, SpaceX, Caterpillar, Pfizer, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 04

U.S. Stocks on the MOVE-Leidos, Marathon Petroleum, Qnity

Reuters
·
Aug 04

Merck 2Q FY26 Net Loss Widens to $1.34 Billion; Sales Rise 5% to $16.61 Billion

Reuters
·
Aug 04

Jefferies Adjusts Price Target on Merck & Co. to $152 From $147, Keeps Buy Rating

MT Newswires Live
·
Aug 04

Merck Beats Q2 Revenue Estimates, Raises FY Revenue Outlook

Reuters
·
Aug 04

Merck & Co Q2 Gardasil Revenue USD 1,169 Million

THOMSON REUTERS
·
Aug 04

Merck cuts FY26 adjusted EPS view to $2.66-$2.76 from $5.04-$5.16

TIPRANKS
·
Aug 04